Jonathan PoyerAug 152 min readBiotech & HealthcareEarnings Season Continues with Beats. Market Poised for a Breakout but Appears Waiting on Rates
Jonathan PoyerAug 152 min readBiotech & HealthcareBiotech Stays Above 50-Day Moving Average and Crown Therapeutics Acquires Revance for $924M
Jonathan PoyerAug 72 min readBiotech & HealthcareA Look at Biotech Earnings Beats and Misses - Overall a Solid Quarter
